Financial statements Alvogen Pharma

Balance sheet of Alvogen Pharma

Share capital:
Share capital:
5 000 PLN
Company deleted from KRS: 2022-03-09
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of ALVOGEN PHARMA

Year
2018
2019
2020
Total assets 39 715 671,98 45 038 010,46 69 260 384,02
A. Fixed assets 3 515 798,30 4 756 707,74 3 380 318,27
B. Current assets 36 199 873,68 40 281 302,72 65 880 065,75
C. Share capital contributions (basic funds) 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00
Total liabilities 39 715 671,98 45 038 010,46 69 260 384,02
A. Equity -9 216 621,13 -11 511 767,34 -11 376 478,67
B. Liabilities and provisions for liabilities 48 932 293,11 56 549 777,80 80 636 862,69
I. Long-term liabilities 220 158,43 1 295 680,60 968 116,07
II. Short-term liabilities 47 742 538,68 53 983 052,37 74 287 047,83
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.